Senior Peptide Analytical Scientist
Dr. Freya Olsen earned her PhD in Analytical Chemistry from the University of Copenhagen. She specializes in peptide characterization using LC-MS/MS, NMR spectroscopy, and circular dichroism. At Novo Nordisk, she led the analytical development team for several peptide therapeutics, establishing quality control protocols that became industry standards.
PhD Analytical Chemistry, University of Copenhagen; MS Pharmaceutical Sciences, University of Oslo
LC-MS/MS, NMR spectroscopy, peptide quality control
Peptide impurity profiling, Forced degradation studies, QC method validation
An evidence-based exploration of Are Peptides A Scam and its applications. Analysis of clinical data, mechanisms, and ex...
An evidence-based exploration of Slu Pp 322 Peptide and its applications. Analysis of clinical data, mechanisms, and exp...
An evidence-based exploration of Viola Alpina Cyclic Peptide and its applications. Analysis of clinical data, mechanisms...
An evidence-based exploration of Do Oral Peptides Work and its applications. Analysis of clinical data, mechanisms, and ...
An evidence-based exploration of M2 Peptide and its applications. Analysis of clinical data, mechanisms, and expert insi...
An evidence-based exploration of Pp 157 Peptide and its applications. Analysis of clinical data, mechanisms, and expert ...
PeptaVolt
License: BUS-2018-09134-MA
GMP: GMP-2023-6103-US
ISO: ISO 9001:2015 / ISO 13485:2016